chrisvoncsefalvay/vaers-outcomes huggingface dataset:
reporter had a funny taste in her mouth and her 2 daughters just got their first Pfizer vaccine and said the same thing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administered in arm right (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSGEUSIA (non-serious), outcome "unknown", described as "reporter had a funny taste in her mouth and her 2 daughters just got their first Pfizer vaccine and said the same thing".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021322781 same product/event, different patient;US-PFIZER INC-2021322709 same product/event, different patient
The patient was incorrectly given the pediatric Moderna vaccination. As of now there are no symptoms. The patient was informed and will let us know if anything occurs.
sore throat; body ache; fever; headache; Swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), PYREXIA (fever), HEADACHE (headache) and LYMPHADENOPATHY (Swollen lymph node) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), PYREXIA (fever), HEADACHE (headache) and LYMPHADENOPATHY (Swollen lymph node). At the time of the report, OROPHARYNGEAL PAIN (sore throat), PAIN (body ache), PYREXIA (fever), HEADACHE (headache) and LYMPHADENOPATHY (Swollen lymph node) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-022474, US-MODERNATX, INC.-MOD-2021-047944 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047944:Crosslinked (MOD21-018080) US-MODERNATX, INC.-MOD-2021-022474:Crosslinked (MOD21-018080)
Rash started developing on stomach. With 3 days sever rash from head to toe. Diaper rash also spread up stomach and back.  Was hospitalized for 5 nights.
about an hour after the administered vaccine the patient reports he developed some mild swelling to his right upper lip that appeared to be slightly white and was tingling.. All symptoms resolved at the time reporting to the ER at 4pm. MD comments: possible minor vaccine reaction minor angioedema which has resolved.
SM developed scattered erythematous papules on stomach and upper legs approx 9 days post vaccination with primary SPV and AVA. Also received FLUMIST same time. Lesions became diffuse on upper legs, stomach and arms within 48 hrs and very pruritic. Many of the lesion were bullous in nature.
Following vaccine administration, 1 week of intermittant shakiness, can't get warm, dizziness and lightheadedness.
Pericarditis/Myocarditis. 12/26/07-records received-DX: myocarditis. Developed right sided chest pain and erythema at vaccination site about 10 days after receiving primary smallpox and anthrax #3. One day after chest pains started he developed a dry cough. Temp 102.3.
Chief Complaint   Pt had fall last night due to "shakiness." Pt was unable to get up by self. Pt found at 0800 this AM by caregiver. Denies injury from fall, on Eliquis  History of Present Illness     Patient is a 79 year old of Dr who is well known to the Hospitalist program. Patient was originally dx with pelvic fracture 12/29/20 with direct admission to hospital until 1/11/21. Readmission to acute care setting 2/22/21 from HCP and then back to hospital 2/25-3/11/21 when she was dc home with home health. Patient states she was doing well until yesterday with "my legs started shaking" while she was up ambulating with her walker and caregiver. She did not fall and had an uneventful day until around 10PM when went to the bathroom and then went to the kitchen. She was using her walker. When she attempted to get back into her bed "my legs just went out" with general weakness to both legs. She gently slide to the floor, no injury with exception to left ankle but not sure of the nature of the injury. She was unable to get up and could not get her phone. She was found at 8AM by caregiver and brought to the ED. Her daughter is at the bedside with her.   Her only new pain at this time is to her left ankle, feeling well otherwise, no recent Rx changes, generally poor intake per daughter. No other new concerns today. No change in chronic lower back pain.   Addendum;  COVID screen + which could account for her weakness in her legs past 24 hours. Has had multiple previous negative screening studies, most recently 3/2/21. Discussed with ID and patient could have contracted since home from hospital. Will make COVID infectious disease team aware.  Left ankle XR was negative for fracture. RICE.
Reported feeling ?uncoordinated? ?as if I had a couple glasses of wine? during check out after 15 min observation. Medics ran vitals on pt and made decision to transport pt to ED for further evaluation.
C/O burning in throat, feeling of swelling to tongue, numbness in both legs below the knees, dizziness diaphoretic. No respiratory distress. Taken by ambulance to Emergency dept. Treated with Benadryl, Solu-Medrol and Zantac.
I have been tested and diagnosed with COVID 19 despite receiving vaccination more than 3 weeks prior
Information has been received from a RN concerning a 4 yr old male with asthma who on 09Jan02 was vaccinated with a dose of varicella virus vaccine live (lot 640311/0794L). The RN reported that the pt developed chickenpox on 14Oct04. The mother of the pt called the doctor's office and said he had 15 lesions on his back and that he was not feeling well. At the time of this report the pt had not recovered and no further information was available. There was no product quality complaint. Additional information has been requested.
Fever; Headache; Extremely tired all day; sleeping most of it; Baby aches; This is a spontaneous report from a contactable Other HCP (patient herself).  This 54-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number not provided), via an unknown route in the left arm, on 17Feb2021 11:45 (at the age of 54-year-old) at single dose for COVID-19 immunisation. No other vaccine was received in four weeks. Relevant medical history included COVID-19 in Apr2020 (mild case). The patient did not have allergies. No relevant concomitant medications were provided. On 17Feb2021 at 22:00, she started with baby aches. On 18Feb2021 at 03:00, she woke up with 99.2 F fever, with extreme body aches and headache. She ran a low fever throughout the day getting as high as 100 F. Extremely tired all day sleeping most of it. Mild case. The patient was not treated for the events. The patient had recovered with sequelae from the events on unknown date in 2021.  Information about batch/lot number has been requested.
No adverse effects; the patient was administered an improperly stored dose of PROQUAD; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.  On 09-SEP-2019, the patient was administered an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin(rHA)(PROQUAD)(lot#R030794, expiration date was 22-APR-2019)(exact dose and route of administration were not reported)for prophylaxis. The administered doses experienced a temperature excursion of 1 to 5 degree Celsius(reported as -14 to 10 degree Celsius(-14.37C)) for 30 minutes. There were no previous temperature excursions. The temperature excursions were detected by a data logger. The sterile diluent used to reconstitute measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin(rHA)(PROQUAD) was properly stored. No adverse effects were reported.
Noticed painful right calf 3/09/2021.  Went to urgent care at hospital on 3/10/2021.  Was given an ultrasound and it was determined that I had a blood clot in my calf vein.  Was given heparin treatment for seven days followed by xarelto.  I have had 2 dvts in the past associated with surgery.  This dvt was listed as unprovoked, however I believe it was caused by the second shot of modern. Was told by doctors to report this to veers.
3-5 minutes p/ immunization given, pt became pale & fainted. In the next 10-15 sec eyes rolled back & there were tonic/clonic movements of her arms & upper body.BP 92/6, P 100.EMS summoned to ER.
Information has been received from a physician concerning an 18 year old female with a history of diabetes, who on approximately 03-SEP-2007, "about one month ago", was vaccinated with the first dose of Gardasil vaccine, IM in the deltoid. Concomitant medication was not reported. On approximately 04-SEP-2007, "the day after vaccination within 24 hours of the dose of Gardasil vaccine", the patient experienced joint pain in the hand and legs. Subsequently about a "day or so" later, the patient recovered from joint pain in the hand and legs. No product quality complaint was involved. Additional information has been requested.
gen sz for 2min x 3 times <12hr p/vax;according to mom no documented fever;
flu; Initial information received from on 15-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who had flu after receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, lot number and expiry date were unknown) via unknown route in unknown administration site for Flu. Information for batch and expiry date was requested.  On an unknown date the patient developed a non-serious flu (influenza) (latency: unknown) following the administration of INFLUENZA VACCINE.  Action taken :not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  Outcome: Unknown
Developed a  left supraclavicular lymph node enlargement about five days  after the vaccination
Pt recvd vax & exp unspecified reaction following Hep B vax; No further details were provided;
Pt recvd Engerix-B vax on 25FEB91 & exp arthralgias 2 wks later; Was treated w/Pred & seeing a specialist; 03JUN91 pt being treated w/meds; joint pain in arms, knees, ankles, & shoulders;
Information has been received from a patient's neighbor referring to the patient of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (strength, dose, dose#, route and lot# not reported). On an unknown date, after the vaccination, the patient contracted shingles. The outcome of the event was unknown. Additional information is not expected since there was no contact details provided.
Report HA started the day of receiving vaccine. Report continuous headache and diarrhea and vomiting started day 15 post vaccination. Treatment: none Outcome: Referred for COVID-19 testing.
27FEB94 seen in ER for fever, earache x 2 days; also sore throat; dx'd for rt om, URI/tonsilitis; given amoxil & APAP for fever; 2MAR94 seen in ER devel heel pain; 1MAR93 mom noticed rash, & swollen lt ankle;  lt knee swollen; HSP
Hours after administration of vaccine: large patches over body of erythema/induration/itching waxing and waning, changing location. Very uncomfortable for 2 days.
Developed tingling , numbness and burning pain in both arms and hand and the right foot 12 hours post vaccination that awoke me from sleep. Numbness and tingling has persistently since vaccination. Pain resolved. No specific nerve distribution, stocking glove like pattern.  24 hours post vaccine developed worsening long covid symptoms: exhaustion, chest pain, cough, shortness of breath.  This has continued to wax and wane since vaccine with overall worsening of all long Covid symptoms.
Received an expired third dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received an expired third dose) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A, 036A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received an expired third dose). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received an expired third dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication listed.   No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-363464 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-363464:MOD21-156364(crosslink) (Master Case)
facial flushing; nausea; vomiting; felt faint; This case was reported by a physician via sales rep and described the occurrence of facial flushing in a adult patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2019-2020 season) (batch number GD44Z, expiry date 30th June 2020) for prophylaxis.   On 1st October 2019, the patient received FluLaval Tetra 2019-2020 season. In October 2019, less than a week after receiving FluLaval Tetra 2019-2020 season, the patient experienced facial flushing, nausea, vomiting and felt faint. On an unknown date, the outcome of the facial flushing, nausea, vomiting and felt faint were unknown.   It was unknown if the reporter considered the facial flushing, nausea, vomiting and felt faint to be related to FluLaval Tetra 2019-2020 season.  Additional details were provided as follows: GlaxoSmithKline sales professional called in and steted her colleague had already reported this adverse event but the GlaxoSmithKline staff who is the reporter today got to speak to the physician on 4th October 2019 morning and obtained clarifications.  The patient identifiers were not available. Around 1st October 2019, the patient received Flulaval vaccine 2019-2020. The patient had facial flushing, they felt faint and also had nausea and vomiting. There were no hospitalization required.  Additional information was not provided.  The reporter consented to follow up. This is 1 of 5 cases reported by the same reporter.
Fever, chills, malaise, and then diarrhea three hours later.  Lasted 48 hours.  Treated only with Tylenol for the fever.  Evening of 10/09/2015 was coming out of bathroom with chills and fever and fell, resulting in a sprained wrist (dx at hospital ER morning of 10/10/2015).
Patient's wife states that he reported a bad headache about 3 hours after vaccination, that had improved by the next morning. The afternoon of 1/27/21, within 24 hours of receiving the vaccine, patient suffered from a stroke.
Started soon after IZ, as small red dots all over body at site of IZ. Then progressed, the next day, to larger red areas (nickel-sized) raised and hard. Mom reported not very itchy. Called pt 3 days later and mom stated was improving.
Patient was administered a Pfizer COVID-19 vaccine that was exposed to a temperature excursion. (Vaccine was between 8-14.5 degrees C for 7 hrs and 48 minutes). Pfizer was contacted and advised the clinic to consider the dose as invalid and to revaccinate. Patient was revaccinated on 03/19/21.
Fever a few days after. Rash showing up yesterday and on my torso and face  Progressively itching and has been spreading more
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 24-year-old male patient received BNT162b2 (BNT162B2), on 20May2021 as dose 1, single (Lot number: EW0171) at the age of 22 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: FATIGUE (non-serious), outcome "recovered"; INFLUENZA LIKE ILLNESS (non-serious), outcome "recovered", described as "Flu like symptoms". Additional information: It was reported that, the patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccines. The family medical history relevant to AE was not provided. Relevant tests were reported as none.
PMR; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: POLYMYALGIA RHEUMATICA (medically significant), outcome "unknown", described as "PMR".  Clinical course: Patient experienced Polymyalgia Rheumatica (PMR) and how patient feel it was directly linked to the Covid-19 vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
took 1st capsule & 24 hrs later had ache & pain; cont taking Vivotif & completed series; has been having problems swallowing; has cont fever 101 & malasia; has loss of appetite & has lost weight;
Pt c/o pain at injection site during vaccination administration. Pt became nauseous, blurred vision, LOC x2 episodes, and diaphoresis. Pt repeatedly stated, "I can't see." Pt hyperventilating at time of arrival to med obs. Assisted in slowing breathing with positive effect. Pt assisted to stretcher from w/c and place in position. Pt reports vision back to almost baseline after repositioning. Pt given apple juice and crackers. Prior to d/c to home, pt reported left eye remained slightly burred and requested her father pick her up at staff suggestion for safety. VS at 1702: BP 57/44, recheck 68/44 (placed in trendelenburg position), HR 65, RR 24, O2 sat 100% on RA. VS at 1710: BP 106/82, HR 66, RR 18, O2 sat 100% on RA. VS at 1715: BP 104/73, HR 61, RR 18, O2 sat 99% on RA. VS at 1728: BP 109/80, HR 62, RR 17, O2 sat 99% on RA. VS at 1733: BP 106/80,, HR 68, RR 18, O2 sat 98% on RA. No s/s of distress at time of discharge. Pt escorted to exit via w/c with staff per protocol.
In between the vaccine he was diagnosed with Covid; In between the vaccine he was diagnosed with Covid; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 53-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 16Jun2021 (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was supposed to return for the second Pfizer COVID 19 Vaccine on 07Jul2021. In between the vaccine he was diagnosed with COVID and missed his appointment for the second vaccine. The patient underwent lab tests which included Sars-cov-2 test: positive on an unspecified date. The caller asked what he should do about receiving the second Pfizer Covid 19 Vaccine. The outcome of the event was unknown.  Information about Lot and batch number requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021882515 same reporter/drug/AE , different patient.
Initially rapid heart rate for 15 min then back to normal.  later was tired,  went to bed early woke up at 2 am and had swelling in face, throat and swollen eyes.  Took Pepcid for itchy eyes.  In the morning took Benadryl and slept on April 2.   Hours later, most of the swelling was gone.  Felt like a cold was coming on, running eyes, running nose, sneezing and loss of taste.  48 hours later, cold symptoms linger feeling tired.  Still feel some swelling in the glands on neck .
Reportedly, the patient received a 3 shot series of Lymerix in the spring of 1999. On 07/23/2001, reportedly, the patient was stung/bitten by an unidentified insect through the shirt at the right scapula. The patient experienced small, instant swelling and redness after the initial sting. There was no pain after the sting until redness and the affected area increased to about 80-100mm. Reportedly, there never was any sign of a tick despite careful checks. On 07/29/2001, reportedly, a double bull's-eye rash appeared. On 07/30/2001 the patient was diagnosed with Lyme disease, for the third time. Ceftin was prescribed for 21 days. On 07/31/2001 at 02:00 experiencing major discomfort in the precise area of the original attack which subsided by 06:00. The patient has had no recurrence so far and was continuing Ceftin. The patient doubts the diagnosis but not the treatment. As of 08/01/2001, the outcome of the event was resolved.
After administering vaccine, pt stated tingling in fingers, lightheadedness, slight high heart rate.  BP was taken (162/90). called 911 pt was then cared for by EMS, BP normalized and pt went home
Patient received monovalent Pfizer COVID vaccine instead of Bivalent booster. Patient will be offered bivalent vaccine in 2 months.
Site reaction, redness, edema, hot to touch at site of injection. Nausea & vomiting approx. 1 hour after vaccine and lasted 24 hours. Treated with Bendryl 150 mg orally 4-6 hours for 48 hours. Cool compresses to area 20 mins four times a day. Symptoms resolved within 48 hour period.